Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela T Soliman

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Gynecologic Oncology|January 30, 2017
Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasiaRudy S Suidan, Weiguo He, Charlotte C Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2019
Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II StudyPamela T Soliman, Shannon N Westin, David A Iglesias, et al.
Obstetrics and Gynecology|August 11, 2018
Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian CancerNicole D Fleming, Alpa M Nick, Robert L Coleman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 9, 2020
Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital chargesKatherine I Stewart, Jarrod S Eska, Ross F Harrison, et al.
Cancer|June 10, 2011
Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinomaShannon N Westin, Charlotte C Sun, Karen H Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2015
Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinomaBrian M Slomovitz, Yunyun Jiang, Melinda S Yates, et al.
Gynecologic Oncology|October 15, 2022
Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional studyKatherine C Kurnit, Silvana Pedra Nobre, Bryan M Fellman, et al.
Gynecologic Oncology|October 21, 2023
Isolated vaginal recurrence in women with stage I endometrial cancerEric Rios-Doria, Han T Cun, Olga T Filippova, et al.
Gynecologic Oncology|May 22, 2019
Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancerBhavana V Chapman, Cameron W Swanick, Matthew S Ning, et al.
Journal of Oncology Practice|October 16, 2019
Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology CenterDonna S Zhukovsky, Pamela T Soliman, Boby Mathew, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Gynecologic Oncology|January 30, 2017
Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasiaRudy S Suidan, Weiguo He, Charlotte C Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2019
Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II StudyPamela T Soliman, Shannon N Westin, David A Iglesias, et al.
Obstetrics and Gynecology|August 11, 2018
Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian CancerNicole D Fleming, Alpa M Nick, Robert L Coleman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 9, 2020
Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital chargesKatherine I Stewart, Jarrod S Eska, Ross F Harrison, et al.
Cancer|June 10, 2011
Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinomaShannon N Westin, Charlotte C Sun, Karen H Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2015
Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinomaBrian M Slomovitz, Yunyun Jiang, Melinda S Yates, et al.
Gynecologic Oncology|October 15, 2022
Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional studyKatherine C Kurnit, Silvana Pedra Nobre, Bryan M Fellman, et al.
Gynecologic Oncology|October 21, 2023
Isolated vaginal recurrence in women with stage I endometrial cancerEric Rios-Doria, Han T Cun, Olga T Filippova, et al.
Gynecologic Oncology|May 22, 2019
Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancerBhavana V Chapman, Cameron W Swanick, Matthew S Ning, et al.
Journal of Oncology Practice|October 16, 2019
Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology CenterDonna S Zhukovsky, Pamela T Soliman, Boby Mathew, et al.
Pageof 15